Skip to content

Evaluation of the Effectiveness of Daily Pulse Lavage Therapy in Chronic Wounds

Bedside Pulse Lavage Irrigation Project

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01500746
Acronym
PLI2
Enrollment
8
Registered
2011-12-28
Start date
2011-12-31
Completion date
2013-10-31
Last updated
2014-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Wounds

Keywords

chronic wound treatment, pulse lavage, serial pulse lavage, wounds, bacterial colonization of wounds

Brief summary

This study evaluates the effectiveness of pulse lavage therapy in decreasing bacterial counts in chronic wounds.

Detailed description

Pulse lavage irrigation is an effective method of cleaning both acute and chronic wounds. The major drawback to pulse irrigation is that it is extremely messy and can easily contaminate the patient's surroundings, putting other patients and the person operating the device at risk. In order to obtain the benefits of pulse lavage, we have created a device that will contain the water spray from the lavage and protect both the patient and their surroundings. Due to the fact that frequent (multiple times daily) pulse lavage therapy has not been possible previously, it is unknown how effectively serial pulse lavage irrigation reduces bacterial counts. This study evaluates the effectiveness of serial pulse lavage therapy in decreasing bacterial counts in chronic wounds.

Interventions

PROCEDUREPulse lavage treatment

A pulse lavage machine will be used to irrigate the wound with a total of 4 liters of water, twice daily, for a total of 4 days (8 treatments).

OTHERDressing changes

Wounds will be treated with moist gauze dressing changes twice daily for a total of 4 days (8 treatments).

Sponsors

Northwestern University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

1. Patients must have a chronic wound (as defined by the wound being present for \>30 days) located on any part of their body 2. The wound must be smaller than 10cm in greatest diameter. 3. Patients must have an expected remaining hospital duration of 4 days 4. Patients must be willing and able to comply with all study procedures

Exclusion criteria

1. Patients must not have undergone any surgical excisions or debridements of the wound in the past 30 days 2. The wound may not undergo any surgical procedures or other treatments other than the study treatments during the course of the study. 3. The wound may not require any immediate surgical intervention or debridement 4. Patients may not start any new antibiotic therapy during the course of the study 5. Must not have an allergy to skin adhesives. 6. Patients must not be taking any immunosuppressive medications. 7. Subjects who, in the opinion of the investigator, may not complete the study for any reason.

Design outcomes

Primary

MeasureTime frameDescription
Change in Bacterial CountsBaseline and at 4 daysA punch biopsy of the wound will be taken once the subject is enrolled in the study. A repeat biopsy will be taken after the 8th lavage treatment or the 8th dressing change. These will be sent for bacterial count analysis and the difference in bacterial counts will be evaluated. The lavage fluid from baseline measurements will be filtered and sent for bacterial counts and will be compared to the filtered fluid from the last lavage treatment. In addition, surface swabs will be taken at the beginning and end of the study and will be sent for bacterial counts as well. Bacterial counts from these lavage, biopsy specimen, and swabs will be averaged and analyzed.
Change in Gene Expression Analysis4 daysA punch biopsy will be taken at the beginning of the study. this will be sent for gene expression analysis. A repeat biopsy at the end of the study will also be sent at the end of the study, and a change in gene expression in analysis will be evaluated.

Secondary

MeasureTime frameDescription
Pain With Lavage Treatments4 daysAfter each lavage treatment, the subjects will complete a visual analogue scale that will determine the level of discomfort that they experienced during the study.

Countries

United States

Participant flow

Recruitment details

Recruitment dates extended from december 2011 to October 2013.

Participants by arm

ArmCount
Lavage Arm
This group will serve as the experimental arm. They will undergo twice daily pulse lavage of their wounds for 4 days. In between the lavage treatments, their wounds will be dressed with moist gauze. Pulse lavage treatment: A pulse lavage machine will be used to irrigate the wound with a total of 4 liters of water, twice daily, for a total of 4 days (8 treatments).
4
Moist Dressings
This group will serve as the control group. They will undergo twice daily dressing changes with moist gauze dressings for a total of 4 days (8 dressing changes). Bacterial counts and gene expression analysis will be performed prior to the first dressing change and after the last dressing change. Dressing changes: Wounds will be treated with moist gauze dressing changes twice daily for a total of 4 days (8 treatments).
4
Total8

Baseline characteristics

CharacteristicLavage ArmMoist DressingsTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
1 Participants0 Participants1 Participants
Age, Categorical
Between 18 and 65 years
3 Participants4 Participants7 Participants
Region of Enrollment
United States
4 participants4 participants8 participants
Sex: Female, Male
Female
0 Participants1 Participants1 Participants
Sex: Female, Male
Male
4 Participants3 Participants7 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 40 / 4
serious
Total, serious adverse events
0 / 40 / 4

Outcome results

Primary

Change in Bacterial Counts

A punch biopsy of the wound will be taken once the subject is enrolled in the study. A repeat biopsy will be taken after the 8th lavage treatment or the 8th dressing change. These will be sent for bacterial count analysis and the difference in bacterial counts will be evaluated. The lavage fluid from baseline measurements will be filtered and sent for bacterial counts and will be compared to the filtered fluid from the last lavage treatment. In addition, surface swabs will be taken at the beginning and end of the study and will be sent for bacterial counts as well. Bacterial counts from these lavage, biopsy specimen, and swabs will be averaged and analyzed.

Time frame: Baseline and at 4 days

ArmMeasureValue (MEAN)
Lavage ArmChange in Bacterial Counts4460 cfu/mL
Moist DressingsChange in Bacterial Counts-1030000 cfu/mL
Primary

Change in Gene Expression Analysis

A punch biopsy will be taken at the beginning of the study. this will be sent for gene expression analysis. A repeat biopsy at the end of the study will also be sent at the end of the study, and a change in gene expression in analysis will be evaluated.

Time frame: 4 days

Secondary

Pain With Lavage Treatments

After each lavage treatment, the subjects will complete a visual analogue scale that will determine the level of discomfort that they experienced during the study.

Time frame: 4 days

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026